Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomedical Research | 10 | 2023 | 371 | 4.140 |
Why?
|
| Community-Institutional Relations | 8 | 2021 | 171 | 3.040 |
Why?
|
| Community-Based Participatory Research | 8 | 2023 | 292 | 3.040 |
Why?
|
| Trust | 7 | 2022 | 119 | 2.720 |
Why?
|
| Clinical Trials as Topic | 10 | 2023 | 195 | 2.530 |
Why?
|
| Minority Groups | 7 | 2022 | 537 | 2.510 |
Why?
|
| Research Subjects | 4 | 2020 | 31 | 2.280 |
Why?
|
| Research Personnel | 5 | 2022 | 133 | 2.220 |
Why?
|
| Research Design | 9 | 2022 | 292 | 1.830 |
Why?
|
| Humans | 75 | 2024 | 34853 | 1.810 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 54 | 1.510 |
Why?
|
| Patient Selection | 6 | 2022 | 154 | 1.420 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 51 | 1.310 |
Why?
|
| Interprofessional Relations | 2 | 2018 | 48 | 1.260 |
Why?
|
| Independent Living | 2 | 2017 | 31 | 1.240 |
Why?
|
| United States | 19 | 2024 | 3894 | 1.210 |
Why?
|
| Alzheimer Disease | 6 | 2020 | 881 | 1.190 |
Why?
|
| Osteoporosis | 4 | 2009 | 32 | 1.160 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 446 | 1.070 |
Why?
|
| Aged | 27 | 2022 | 6448 | 1.070 |
Why?
|
| Cognition Disorders | 8 | 2012 | 233 | 1.060 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 205 | 1.020 |
Why?
|
| Female | 38 | 2024 | 19873 | 1.020 |
Why?
|
| Middle Aged | 25 | 2024 | 9642 | 0.990 |
Why?
|
| Health Status Disparities | 2 | 2020 | 583 | 0.980 |
Why?
|
| Male | 34 | 2024 | 18870 | 0.970 |
Why?
|
| Neoplasms | 3 | 2022 | 1033 | 0.920 |
Why?
|
| Lung Diseases | 1 | 2024 | 56 | 0.920 |
Why?
|
| Cardiovascular System | 1 | 2023 | 30 | 0.920 |
Why?
|
| Community Health Services | 3 | 2022 | 175 | 0.900 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 254 | 0.890 |
Why?
|
| Access to Information | 2 | 2020 | 13 | 0.890 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 147 | 0.870 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 151 | 0.850 |
Why?
|
| Comparative Effectiveness Research | 2 | 2018 | 14 | 0.850 |
Why?
|
| Pilot Projects | 5 | 2022 | 628 | 0.840 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 37 | 0.830 |
Why?
|
| Cognition | 3 | 2017 | 373 | 0.830 |
Why?
|
| Financing, Government | 1 | 2021 | 18 | 0.800 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 160 | 0.800 |
Why?
|
| Mammography | 3 | 2019 | 176 | 0.800 |
Why?
|
| Disability Evaluation | 2 | 2013 | 56 | 0.790 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 2561 | 0.770 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2021 | 790 | 0.770 |
Why?
|
| Attitude of Health Personnel | 3 | 2021 | 186 | 0.760 |
Why?
|
| Education, Distance | 1 | 2021 | 40 | 0.760 |
Why?
|
| Needs Assessment | 2 | 2018 | 159 | 0.740 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 316 | 0.730 |
Why?
|
| Vitamin D Deficiency | 4 | 2009 | 94 | 0.720 |
Why?
|
| Schools, Medical | 1 | 2021 | 192 | 0.720 |
Why?
|
| Schizophrenia | 1 | 2020 | 73 | 0.720 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 68 | 0.720 |
Why?
|
| Focus Groups | 7 | 2022 | 307 | 0.710 |
Why?
|
| Organizational Culture | 1 | 2018 | 12 | 0.680 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 53 | 0.670 |
Why?
|
| Adult | 15 | 2024 | 11034 | 0.670 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 465 | 0.660 |
Why?
|
| Managed Care Programs | 1 | 2018 | 35 | 0.660 |
Why?
|
| Group Processes | 2 | 2019 | 21 | 0.660 |
Why?
|
| Executive Function | 3 | 2017 | 47 | 0.660 |
Why?
|
| Qualitative Research | 6 | 2021 | 393 | 0.660 |
Why?
|
| Social Perception | 1 | 2018 | 59 | 0.650 |
Why?
|
| Education, Medical | 1 | 2019 | 97 | 0.650 |
Why?
|
| Health Services Research | 1 | 2018 | 133 | 0.640 |
Why?
|
| Geriatric Assessment | 4 | 2013 | 52 | 0.640 |
Why?
|
| Universities | 1 | 2021 | 363 | 0.640 |
Why?
|
| Patient Participation | 1 | 2018 | 68 | 0.640 |
Why?
|
| Health Education | 2 | 2020 | 304 | 0.640 |
Why?
|
| Phenotype | 1 | 2020 | 650 | 0.640 |
Why?
|
| Health Literacy | 2 | 2019 | 100 | 0.630 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 104 | 0.630 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 118 | 0.630 |
Why?
|
| Health Occupations | 1 | 2017 | 15 | 0.620 |
Why?
|
| Interinstitutional Relations | 1 | 2017 | 35 | 0.620 |
Why?
|
| Dementia | 2 | 2009 | 133 | 0.610 |
Why?
|
| Cultural Competency | 2 | 2018 | 120 | 0.600 |
Why?
|
| Medically Underserved Area | 1 | 2017 | 98 | 0.600 |
Why?
|
| Hypertension | 1 | 2024 | 770 | 0.590 |
Why?
|
| Aged, 80 and over | 10 | 2022 | 2333 | 0.580 |
Why?
|
| Physicians | 1 | 2018 | 148 | 0.580 |
Why?
|
| Asthma | 1 | 2020 | 363 | 0.570 |
Why?
|
| Awards and Prizes | 3 | 2023 | 27 | 0.570 |
Why?
|
| Tennessee | 3 | 2021 | 59 | 0.560 |
Why?
|
| Pharmaceutical Services | 2 | 2015 | 22 | 0.530 |
Why?
|
| Medication Therapy Management | 1 | 2015 | 12 | 0.530 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 34 | 0.530 |
Why?
|
| Capacity Building | 1 | 2015 | 78 | 0.500 |
Why?
|
| Obesity | 2 | 2024 | 965 | 0.500 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 77 | 0.480 |
Why?
|
| Program Evaluation | 1 | 2015 | 316 | 0.480 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 152 | 0.470 |
Why?
|
| Mass Screening | 3 | 2021 | 427 | 0.450 |
Why?
|
| Risk Factors | 7 | 2020 | 3414 | 0.400 |
Why?
|
| Age of Onset | 3 | 2012 | 98 | 0.400 |
Why?
|
| Neuropsychological Tests | 6 | 2013 | 255 | 0.390 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 901 | 0.370 |
Why?
|
| Bone Density Conservation Agents | 2 | 2007 | 22 | 0.370 |
Why?
|
| Bone Density | 4 | 2017 | 76 | 0.370 |
Why?
|
| Information Dissemination | 2 | 2020 | 58 | 0.360 |
Why?
|
| Health Personnel | 2 | 2021 | 200 | 0.360 |
Why?
|
| Incidence | 3 | 2019 | 882 | 0.330 |
Why?
|
| Retrospective Studies | 5 | 2022 | 1961 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 592 | 0.320 |
Why?
|
| Young Adult | 5 | 2022 | 4012 | 0.320 |
Why?
|
| Interviews as Topic | 2 | 2019 | 356 | 0.310 |
Why?
|
| Disabled Persons | 1 | 2007 | 60 | 0.300 |
Why?
|
| Depression | 2 | 2012 | 664 | 0.290 |
Why?
|
| Fractures, Bone | 1 | 2007 | 51 | 0.290 |
Why?
|
| Psychometrics | 3 | 2018 | 292 | 0.290 |
Why?
|
| Mood Disorders | 1 | 2006 | 43 | 0.290 |
Why?
|
| Fractures, Spontaneous | 1 | 2005 | 6 | 0.280 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 531 | 0.270 |
Why?
|
| Vitamin D | 4 | 2009 | 176 | 0.260 |
Why?
|
| Depressive Disorder, Major | 3 | 2012 | 102 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1056 | 0.260 |
Why?
|
| Poverty | 1 | 2007 | 316 | 0.260 |
Why?
|
| Densitometry | 1 | 2004 | 13 | 0.250 |
Why?
|
| Demography | 2 | 2020 | 167 | 0.250 |
Why?
|
| Communication | 3 | 2023 | 170 | 0.240 |
Why?
|
| Mediastinum | 1 | 2023 | 5 | 0.240 |
Why?
|
| Cerebrovascular Disorders | 3 | 2010 | 37 | 0.240 |
Why?
|
| Sertraline | 3 | 2012 | 7 | 0.240 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1426 | 0.230 |
Why?
|
| Adolescent | 4 | 2022 | 5035 | 0.230 |
Why?
|
| Missouri | 2 | 2017 | 7 | 0.220 |
Why?
|
| Antidepressive Agents | 3 | 2012 | 53 | 0.220 |
Why?
|
| Aspirin | 1 | 2022 | 45 | 0.220 |
Why?
|
| Censuses | 1 | 2022 | 24 | 0.210 |
Why?
|
| Socioeconomic Factors | 2 | 2023 | 1003 | 0.210 |
Why?
|
| Heart | 1 | 2023 | 178 | 0.210 |
Why?
|
| Age Factors | 2 | 2019 | 1007 | 0.210 |
Why?
|
| Connecticut | 1 | 2021 | 14 | 0.200 |
Why?
|
| South Carolina | 1 | 2021 | 19 | 0.200 |
Why?
|
| Treatment Outcome | 4 | 2020 | 1349 | 0.200 |
Why?
|
| North Carolina | 1 | 2021 | 103 | 0.200 |
Why?
|
| Papillomaviridae | 1 | 2022 | 125 | 0.200 |
Why?
|
| Adrenergic Agonists | 1 | 2020 | 2 | 0.190 |
Why?
|
| Patient Care | 1 | 2020 | 28 | 0.190 |
Why?
|
| Genomics | 1 | 2022 | 201 | 0.190 |
Why?
|
| Chronic Disease | 1 | 2024 | 469 | 0.190 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 75 | 0.190 |
Why?
|
| Schizophrenic Psychology | 1 | 2020 | 17 | 0.190 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 217 | 0.180 |
Why?
|
| Communication Barriers | 1 | 2020 | 53 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 26 | 0.180 |
Why?
|
| Social Welfare | 1 | 2019 | 30 | 0.180 |
Why?
|
| Health Resources | 1 | 2019 | 32 | 0.170 |
Why?
|
| Cultural Diversity | 1 | 2020 | 158 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2019 | 63 | 0.170 |
Why?
|
| Social Responsibility | 1 | 2018 | 12 | 0.170 |
Why?
|
| Patient Advocacy | 1 | 2018 | 20 | 0.170 |
Why?
|
| Southeastern United States | 1 | 2018 | 48 | 0.170 |
Why?
|
| Brain | 3 | 2012 | 1268 | 0.170 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 141 | 0.170 |
Why?
|
| Trail Making Test | 1 | 2017 | 3 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2019 | 136 | 0.160 |
Why?
|
| Culture | 1 | 2019 | 162 | 0.160 |
Why?
|
| Health Promotion | 1 | 2024 | 588 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 468 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 207 | 0.160 |
Why?
|
| Logistic Models | 1 | 2020 | 894 | 0.160 |
Why?
|
| Socialization | 1 | 2017 | 20 | 0.160 |
Why?
|
| Educational Status | 1 | 2019 | 295 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 311 | 0.150 |
Why?
|
| Comorbidity | 3 | 2009 | 606 | 0.150 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 198 | 0.150 |
Why?
|
| Health Surveys | 1 | 2018 | 358 | 0.150 |
Why?
|
| Diphosphonates | 2 | 2007 | 10 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 2007 | 36 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 189 | 0.140 |
Why?
|
| Affect | 1 | 2017 | 147 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 90 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 159 | 0.140 |
Why?
|
| Pharmacists | 2 | 2015 | 53 | 0.130 |
Why?
|
| Public Opinion | 1 | 2015 | 16 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2015 | 196 | 0.130 |
Why?
|
| Creatinine | 1 | 2015 | 101 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2021 | 487 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 423 | 0.130 |
Why?
|
| Health Status | 1 | 2017 | 356 | 0.130 |
Why?
|
| Program Development | 1 | 2015 | 225 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 775 | 0.120 |
Why?
|
| Lipids | 1 | 2015 | 222 | 0.120 |
Why?
|
| Papillomavirus Vaccines | 1 | 2015 | 136 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2015 | 165 | 0.110 |
Why?
|
| Leadership | 1 | 2013 | 63 | 0.110 |
Why?
|
| Personality Inventory | 1 | 2012 | 73 | 0.110 |
Why?
|
| Mental Status Schedule | 2 | 2012 | 14 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2012 | 30 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 841 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 424 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2015 | 613 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 274 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 211 | 0.090 |
Why?
|
| Psychology | 1 | 2009 | 32 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 32 | 0.090 |
Why?
|
| Femur | 1 | 2009 | 35 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 29 | 0.090 |
Why?
|
| Probability | 1 | 2009 | 75 | 0.090 |
Why?
|
| ROC Curve | 1 | 2009 | 138 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 78 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1681 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 964 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2009 | 114 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2007 | 59 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2007 | 44 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2007 | 9 | 0.080 |
Why?
|
| Calcitonin | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2022 | 1422 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2006 | 33 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 44 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 28 | 0.070 |
Why?
|
| Hippocampus | 2 | 2012 | 546 | 0.070 |
Why?
|
| Institutionalization | 1 | 2005 | 1 | 0.070 |
Why?
|
| Spinal Fractures | 1 | 2005 | 3 | 0.070 |
Why?
|
| Lewy Bodies | 1 | 2006 | 28 | 0.070 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2006 | 17 | 0.070 |
Why?
|
| Social Environment | 1 | 2007 | 186 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2005 | 26 | 0.070 |
Why?
|
| Weight Loss | 1 | 2006 | 124 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2005 | 26 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 112 | 0.070 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 292 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2005 | 64 | 0.070 |
Why?
|
| Ketanserin | 1 | 2004 | 4 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 16 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2007 | 283 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2004 | 79 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2005 | 202 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 393 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2007 | 727 | 0.060 |
Why?
|
| Algorithms | 2 | 2022 | 435 | 0.060 |
Why?
|
| Age Distribution | 1 | 2004 | 223 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2004 | 166 | 0.060 |
Why?
|
| Calcium | 1 | 2005 | 445 | 0.060 |
Why?
|
| Ecosystem | 1 | 2023 | 119 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2022 | 75 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2022 | 65 | 0.050 |
Why?
|
| Linear Models | 2 | 2015 | 253 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 1425 | 0.050 |
Why?
|
| Publications | 1 | 2020 | 6 | 0.050 |
Why?
|
| Latin America | 1 | 2020 | 41 | 0.050 |
Why?
|
| Neural Pathways | 2 | 2012 | 120 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 233 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 608 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 119 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2017 | 2 | 0.040 |
Why?
|
| Telephone | 1 | 2017 | 32 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2017 | 3 | 0.040 |
Why?
|
| Religion | 1 | 2018 | 77 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2012 | 1353 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2008 | 108 | 0.030 |
Why?
|
| Emotions | 1 | 2018 | 204 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 330 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 429 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 269 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 903 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 415 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 1 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 19 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2012 | 49 | 0.030 |
Why?
|
| Parents | 1 | 2015 | 288 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 148 | 0.030 |
Why?
|
| Reaction Time | 1 | 2012 | 130 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 67 | 0.030 |
Why?
|
| Amygdala | 1 | 2012 | 110 | 0.030 |
Why?
|
| Memory | 1 | 2012 | 165 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 243 | 0.020 |
Why?
|
| Child | 1 | 2015 | 2875 | 0.020 |
Why?
|
| Physical Examination | 1 | 2006 | 40 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 2004 | 11 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 404 | 0.020 |
Why?
|
| Protein Binding | 1 | 2004 | 913 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 639 | 0.010 |
Why?
|
| Pharmacies | 1 | 1954 | 19 | 0.010 |
Why?
|
| Pharmacy | 1 | 1954 | 26 | 0.010 |
Why?
|